InsiderTrades.com logo

VBIO Insider Trading

Insider Ownership Percentage: 2.50%
Insider Buying (Last 12 Months): $28,450.00
Insider Selling (Last 12 Months): $0.00

Valion Bio, Inc. Common Stock Insider Trading History Chart

This chart shows the insider buying and selling history at Valion Bio, Inc. Common Stock by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Valion Bio, Inc. Common Stock Share Price & Price History

Current Price: $0.16
Price Change: ▼ Price Decrease of -0.0219 (-12.00%)
As of 08/18/2026 04:00 PM ET

This chart shows the closing price history over time for VBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Valion Bio, Inc. Common Stock Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/15/2026Sheryle BoltonDirectorBuy10,000$1.04$10,400.0010,000View SEC Filing Icon  
4/1/2026Christina Rizopoulos ValauriDirectorBuy19,000$0.95$18,050.0019,000View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Valion Bio, Inc. Common Stock (NASDAQ:VBIO)

4.25% of Valion Bio, Inc. Common Stock stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at VBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Valion Bio, Inc. Common Stock Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/8/2026Foster & Motley Inc.53,728$2.72M0.1%N/A1.295%Search for SEC Filing on Google Icon
8/8/2026HS Management Partners LLC41,229$14.15M4.9%N/A0.993%Search for SEC Filing on Google Icon
8/19/2025Marex Group plc39,283$0.16M0.0%N/A3.637%Search for SEC Filing on Google Icon
8/9/2024Warberg Asset Management LLC80,000$31K0.0%N/A1.294%Search for SEC Filing on Google Icon
5/26/2023Sheets Smith Wealth Management600,000$91K0.0%N/A2.022%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Valion Bio, Inc. Common Stock logo
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
Read More on Valion Bio, Inc. Common Stock

Today's Range

Now: $0.16
Low: $0.15
High: $0.18

50 Day Range

MA: $0.42
Low: $0.16
High: $0.80

52 Week Range

Now: $0.16
Low: $0.15
High: $3.66

Volume

10,494,674 shs

Average Volume

17,648,602 shs

Market Capitalization

$666.65 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.85

Who are the company insiders with the largest holdings of Valion Bio, Inc. Common Stock?

Valion Bio, Inc. Common Stock's top insider shareholders include:
  1. Christina Rizopoulos Valauri (Director)
  2. Sheryle Bolton (Director)
Learn More about top insider investors at Valion Bio, Inc. Common Stock.

Who are the major institutional investors of Valion Bio, Inc. Common Stock?

Valion Bio, Inc. Common Stock's top institutional investors include:
  1. Foster & Motley Inc. — 1.29%
  2. HS Management Partners LLC — 0.99%
Learn More about top institutional investors of Valion Bio, Inc. Common Stock stock.

Which institutional investors are buying Valion Bio, Inc. Common Stock stock?

Within the previous quarter, VBIO stock was bought by institutional investors including:
  1. Foster & Motley Inc.
  2. HS Management Partners LLC
In the previous year, these company insiders have bought Valion Bio, Inc. Common Stock stock:
  1. Christina Rizopoulos Valauri (Director)
  2. Sheryle Bolton (Director)
Learn More investors buying Valion Bio, Inc. Common Stock stock.